Cargando…

Assessment of Medication Adherence and Pharmacist Intervention Are Important for the Care of Patients with Inflammatory Bowel Disease

Detalles Bibliográficos
Autores principales:	Kim, Eun Sil, Kang, Ben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474492/ https://www.ncbi.nlm.nih.gov/pubmed/36104209 http://dx.doi.org/10.5009/gnl220358

Ejemplares similares

Optimizing Medication Access and Use in Inflammatory Bowel Disease: The Roles and Impact of Clinical Pharmacists and Pharmacy Technicians
por: Bhat, Shubha
Publicado: (2023)

Medication adherence in inflammatory bowel disease
por: Chan, Webber, et al.
Publicado: (2017)

The CLEO assessment tool for pharmacist interventions
por: Eriksson, Tommy
Publicado: (2021)

Assessing Oral Medication Adherence and Identifying Predictors of Low Adherence in Chinese Inflammatory Bowel Disease Patients
por: Hu, Wen, et al.
Publicado: (2020)

Challenges of modern day transition care in inflammatory bowel disease: From inflammatory bowel disease to biosimilars
por: Hakizimana, Ali, et al.
Publicado: (2017)

Online Mindfulness Intervention for Inflammatory Bowel Disease: Adherence and Efficacy
por: Forbes, Leila, et al.
Publicado: (2022)

The importance of pharmacists in modern day surgery – editorial
por: Wireko, Andrew A., et al.
Publicado: (2023)

Inflammatory Bowel Diseases: Current Medical and Surgical Therapy
por: Neurath, Markus F., et al.
Publicado: (2015)

Pharmacists’ and patients’ perceptions about the importance of pharmacist services types to improve medication adherence among patients with diabetes in Indonesia
por: Presley, Bobby, et al.
Publicado: (2021)

Applying Endoscopic Interventions to Inflammatory Bowel Disease-Related Strictures
por: Lightner, Amy L
Publicado: (2020)

Home-based fecal calprotectin test is expected to play an important role in patients with inflammatory bowel diseases
por: Kim, Young-Ho
Publicado: (2018)

Pharmacists’ Confidence in Managing Patients with Inflammatory Bowel Disease
por: Prasad, Sharmila S., et al.
Publicado: (2020)

Medication non-adherence in inflammatory bowel diseases is associated with disability
por: Perry, Jonathan, et al.
Publicado: (2018)

Adherence to Inflammatory Bowel Disease Medications in Southern New Zealand
por: Aluzaite, Kristina, et al.
Publicado: (2021)

Improvement in Medication Adherence after Pharmacist Intervention Is Associated with Favorable Clinical Outcomes in Patients with Ulcerative Colitis
por: Kim, Jae Song, et al.
Publicado: (2022)

Inflammatory bowel disease: Clinical screening and transition of care
por: Al-Bawardy, Badr
Publicado: (2017)

Medication non‐adherence as a cause of apixaban failure in venous thromboembolism: The importance of pharmacist medication reconciliation
por: Jethwa, Trisha E, et al.
Publicado: (2022)

Clinical Pharmacist Intervention in a Primary Care Medical Group Reduces Financial Losses
por: Curtiss, Frederic R.
Publicado: (2004)

Micronutrients Should Be Monitored in the Real Practice for Korean Inflammatory Bowel Disease Patients
por: Kim, Seong-Eun
Publicado: (2017)

Roles of Clinical Pharmacists in Caring for Patients With Inflammatory Bowel Disease During COVID-19
por: Bhat, Shubha, et al.
Publicado: (2021)

Inflammatory Bowel Disease
por: Sachar, David B., et al.
Publicado: (2012)

Current Practice and Perception of Screening for Medication Adherence in Inflammatory Bowel Disease
por: Trindade, Arvind J., et al.
Publicado: (2011)

Interventional Tools to Improve Prescription and Adherence to Medical Plans
por: Costa, Elísio, et al.
Publicado: (2015)

Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system
por: Cutler, Rachelle Louise, et al.
Publicado: (2019)

Inflammatory bowel disease is no longer a risk factor of viral hepatitis infection in Asia
por: Kim, Eun Soo
Publicado: (2017)

Poor Clinician Adherence to Inflammatory Bowel Disease Guidelines: How Do We Remedy the Situation?
por: Hart, Lara, et al.
Publicado: (2022)

Disease Management, Pay-for-Performance, and Clinical Pharmacist Interventions in Diabetes Care
por: Curtiss, Frederic R.
Publicado: (2003)

Medication-Related Knowledge and Medication Adherence in Pediatric and Adolescent Patients with Inflammatory Bowel Disease
por: Lim, Jong Keon, et al.
Publicado: (2020)

Pharmacist-Led Interventions to Improve Medication Adherence in Older Adults: A Meta-Analysis
por: Marcum, Zachary, et al.
Publicado: (2021)

Improving adherence towards bowel preparation for colonoscopy
por: Mahadeva, Sanjiv
Publicado: (2023)

Regional variations in the prevalence of primary sclerosing cholangitis associated with inflammatory bowel disease
por: Kim, Kwang Woo, et al.
Publicado: (2023)

Bowel Preparation in Inflammatory Bowel Disease—A Necessary Evil?
por: Lightner, Amy L
Publicado: (2020)

Serum Procalcitonin Is a Candidate Biomarker to Differentiate Bacteremia from Disease Flares in Patients with Inflammatory Bowel Disease
por: Kim, Seong-Eun
Publicado: (2016)

Where are the Ambulatory Care Pediatric Pharmacists?
por: Parrish, Richard H., et al.
Publicado: (2019)

Proprietary Pharmacists and State Medical Association Journals
Publicado: (1905)

Oral Cancer Therapy: The Importance of Adherence
Publicado: (2017)

Dietary role in the development and treatment of inflammatory bowel disease
por: Kim, Jae Young
Publicado: (2020)

Evaluating Disability in Inflammatory Bowel Diseases: A Step Forward for Improved Care
por: Torres, Joana
Publicado: (2015)

Is there a potential role of fecal microbiota transplantation in the treatment of inflammatory bowel disease?
por: Eun, Chang Soo
Publicado: (2017)

Colon importance in short bowel syndrome
por: Lambe, Cecile, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vcb4m7pv7nifhc5jqlinob88fo